The latest announcement is out from Aclaris Therapeutics (ACRS).
On May 7, 2024, investors should tune in for a crucial conference call where the Registrant will update on corporate developments, complemented by a detailed slide presentation. Although this presentation is an integral part of the report, it’s important to note that the information provided does not carry legal weight as an official filing under Section 18 of the Exchange Act, nor will it be included in future filings, unless specifically referenced.
For an in-depth examination of ACRS stock, go to TipRanks’ Stock Analysis page.
